Last edition
News about "Brooke Boyarsky Pratt"
Novo Nordisk Introduces Wegovy Pill with knownwell as NovoCare Provider
Novo Nordisk has launched Wegovy in an oral pill form, marking the first FDA-approved oral GLP-1 therapy, with knownwell recognised as a NovoCare provider to support broader patient access to clinician-led metabolic care across the US.
Brooke Boyarsky Pratt | 06/01/2026 | By News Bureau | 138
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members